Brainsway Establishes US Subsidiary To Promote Deep TMS Treatment

January 1. 2015 | The Israeli company Brainsway, developing a unique treatment for brain disorders, announced that due to increased interest in the United States, it will launch a subsidiary in the US. Brainsway USA is already working towards recruiting key personnel and is working towards building a versatile team of employees that will expand the company in the US. Brainsway develops and markets Deep TMS (Deep Transcranial Magnetic Stimulation) systems for the treatment of brain disorders, a technology based on patents filed with the National Institutes of Health. The use of the company’s technology for the treatment of depression was recently approved by the US Food & Drug Administration.